Texas Capital Bank Wealth Management Services Inc Buys 2,009 Shares of Danaher Corporation $DHR

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Texas Capital Bank Wealth Management Services Inc grew its stake in Danaher Corporation (NYSE:DHR - Free Report) by 6.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,763 shares of the conglomerate's stock after purchasing an additional 2,009 shares during the quarter. Texas Capital Bank Wealth Management Services Inc's holdings in Danaher were worth $7,126,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. FAS Wealth Partners Inc. raised its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after purchasing an additional 1,639 shares in the last quarter. MGO One Seven LLC raised its holdings in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after purchasing an additional 20,813 shares in the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in Danaher in the 1st quarter worth $539,000. Horizon Financial Services LLC raised its holdings in Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after purchasing an additional 8,160 shares in the last quarter. Finally, EFG Asset Management Americas Corp. raised its holdings in Danaher by 13.1% in the 1st quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after purchasing an additional 4,191 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

Shares of NYSE DHR opened at $209.32 on Tuesday. The firm's 50-day moving average price is $200.14 and its 200-day moving average price is $199.45. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a market cap of $149.88 billion, a PE ratio of 44.54, a PEG ratio of 2.94 and a beta of 0.73. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.72 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Analysts Set New Price Targets

DHR has been the subject of several research reports. Leerink Partners increased their price target on shares of Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 23rd. HSBC decreased their price target on shares of Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Barclays reiterated an "overweight" rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Guggenheim reiterated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Three analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.